pharmaceutical combination to treat and / or prevent fibroid and / or endometriosis, use of resveratrol and progestogen, pharmaceutical composition for treatment and / or prevention of fibroid and / or endometriosis drug for treatment and / or prevention of fibroid and / or endometriosis, kit and Method for the treatment and / or prevention of fibroid and / or endometriosis
WO2008131505A1
Osmotic form for controlled release of active principles
BRPI0606001A
use of two preparations comprising distinct amounts of estrogen and estrogen + progestogen and use of one or more elements allowing for unit release
BRPI0418963A
localized fat reduction composition, use of pharmaceutically acceptable surfactant compounds and methods for localized fat reduction
BR0106601A
Pharmaceutical composition containing bisphosphonate for the treatment of diseases related to calcium and / or phosphate metabolism, their use in the preparation of medicament for the treatment of diseases related to calcium and / or phosphate metabolism, method of treating diseases related to calcium metabolism and / or phosphate
BR0105486A
New pharmaceutical compound, its processes for obtaining and pharmaceutical compositions containing the same
BR0105282A
Set comprising packaging and multiparticulate composition containing acetylsalicylic acid
BR0101880A
A new pharmaceutical composition
BR0003282A
Pharmaceutical association for the treatment of arterial hypertension and the prevention of other cardiovascular diseases, such as myocardial infarction, stroke and heart and kidney failure
BR9905674A
A programmed-release pharmaceutical formulation
BR9905261A
A new programmed-release drug association
BR9707748A
Glucocorticoid for the treatment of rheumatic diseases.
